Trials / Withdrawn
WithdrawnNCT03923361
Neural and Antidepressant Effects of Propofol (Phase 2)
- Status
- Withdrawn
- Phase
- Phase 2 / Phase 3
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Utah · Academic / Other
- Sex
- All
- Age
- 18 Years – 55 Years
- Healthy volunteers
- Not accepted
Summary
Moderate-intensity propofol treatments will be administered to participants who are non-responders at the end of Phase 1.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Diprivan | Similar to the high-intensity propofol treatments in Phase 1, the anesthesiologist will administer an induction dose of propofol followed by a continuous infusion, insert an airway, and begin mechanical ventilation. Propofol dosing will be adjusted with the goal of achieving a burst-suppression state with a SR of 40-60 for 12-15 minutes. |
Timeline
- Start date
- 2019-04-16
- Primary completion
- 2024-03-01
- Completion
- 2024-07-01
- First posted
- 2019-04-22
- Last updated
- 2019-12-18
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03923361. Inclusion in this directory is not an endorsement.